Diagnostic Evaluation and Treatment Plan
This patient requires urgent evaluation for adrenal cortical carcinoma (ACC) given the concerning imaging characteristics (53 HU, 3 cm mass) combined with hypercortisolism and hypokalemia, followed by open adrenalectomy if malignancy is confirmed.
Immediate Diagnostic Workup
Complete Hormonal Assessment
The hypercortisolism and hypokalemia suggest either Cushing's syndrome or primary aldosteronism, but the imaging characteristics raise significant concern for malignancy 1.
Required tests:
- 24-hour urinary free cortisol to confirm cortisol excess 1
- ACTH level to determine if cortisol secretion is ACTH-independent (adrenal source) 1
- Plasma aldosterone and renin activity with aldosterone-to-renin ratio, as hypokalemia with hypertension suggests possible aldosterone excess 1
- Plasma fractionated metanephrines and normetanephrines to exclude pheochromocytoma before any surgical intervention 2
- Serum DHEA-S and sex hormones to assess for androgen excess, which occurs in ~60% of ACCs 1
Critical Imaging Interpretation
The 53 HU attenuation is highly concerning for malignancy. On unenhanced CT, a threshold of 10 HU distinguishes benign adenomas from potentially malignant lesions 1. Your patient's mass at 53 HU far exceeds this threshold, placing it in the high-risk category.
Additional imaging required:
- Contrast washout study at 15 minutes: If washout is <60%, this further supports malignancy 1
- Chemical-shift MRI for superior differentiation of benign from malignant tumors, as malignant tumors typically lack intracellular lipid 1
- CT chest, abdomen, and pelvis to evaluate for metastases and local invasion 1
Malignancy Risk Assessment
Multiple red flags for adrenocortical carcinoma are present:
- HU >10 on unenhanced CT (yours is 53 HU) 1
- Size at 3 cm with hormone hypersecretion 1
- Hypokalemia suggesting possible dual hormone secretion (cortisol + aldosterone), which increases malignancy suspicion 1
The guidelines specifically state that malignancy should be suspected if the tumor is lipid-poor, does not wash out on contrast-enhanced CT, is larger than 3 cm, or is secreting more than one hormone 1.
Treatment Algorithm
If Malignancy is Confirmed or Highly Suspected:
Open adrenalectomy is mandatory (not laparoscopic) because:
- Tumors with high malignancy risk have increased risk for local recurrence and peritoneal spread with laparoscopic approach 1
- These tumors are prone to rupture 1
- Complete resection with removal of adjacent lymph nodes is required 1
If Benign Cortisol-Secreting Adenoma:
Laparoscopic adrenalectomy is appropriate 1, followed by:
- Postoperative corticosteroid supplementation until HPA axis recovery (6-18 months) 2, 1
- Perioperative stress-dose steroids 2
Medical Management Pre-operatively:
Immediate symptom control is essential:
- Ketoconazole 400-1200 mg/day for hypercortisolism control 1
- Aggressive potassium replacement for severe hypokalemia
- Spironolactone or eplerenone if primary aldosteronism is confirmed 1
Critical Pitfalls to Avoid
Never perform biopsy before excluding pheochromocytoma biochemically—this could precipitate hypertensive crisis 2
Do not attempt laparoscopic resection if imaging suggests malignancy—this significantly worsens outcomes 1
Do not delay surgery for medical optimization in confirmed ACC—surgical resection is the only curative treatment 1
Ensure adequate perioperative steroid coverage to prevent adrenal crisis, as the contralateral adrenal is likely suppressed from autonomous cortisol secretion 2, 1
Follow-up Post-operatively
If malignancy is confirmed:
- Imaging and biomarkers every 3-6 months 1
- Consider adjuvant radiation if tumor spillage or close margins 1
- Mitotane may be considered for adjuvant therapy in high-grade tumors 1
The combination of high HU value (53), hypercortisolism, and hypokalemia in a 3 cm mass creates a clinical picture highly suspicious for adrenocortical carcinoma, warranting aggressive diagnostic evaluation and likely open surgical resection.